Legislators in Florida and Connecticut have filed new measures to reform state legislations on psychedelic mushrooms.
Rep. Michael Grieco filed a bill in Florida last week. The legislation would establish the legal therapeutic use of psilocybin in the state, which is similar to a measure that voters in Oregon passed in November 2020.
The main goal of Florida’s initiative is to promote the treatment of various mental health conditions with the help of psilocybin. In addition, Florida’s measure would deprioritize the criminal enforcement of various psychedelic fungi and plants.
Florida’s initiative states that psilocybin has demonstrated safety, tolerability and efficacy in the treatment of various mental health conditions such as end-of-life psychological distress, anxiety disorders, depression and addiction, adding that the state has one of the highest mental illness prevalence rates among adults in the country.
If Florida’s measure is approved, the Department of Health would be in charge of enacting regulations that would permit individuals aged 21 and older to access psilocybin therapy in a clinical setting at licensed facilities. Additionally, an advisory board whose work would be to make regulatory recommendations, would be set up in the department.
The bill has various priorities, among them is redirecting policing resources from criminalizing individuals over psychedelics, developing a long-term plan to facilitate the therapeutic use of psilocybin to decrease the prevalence of mental illness and educating the public about the effective and safe use of psilocybin.
The measure states that law enforcement departments throughout the state shall arrest and investigate individuals who are 18 years and above, who may be in possession of or engaged in the distribution, transportation, purchasing, cultivation or noncommercial planting of entheogenic fungi and plants, one of its lowest enforcement priorities. This, the measure continues, includes any fungus or plants of any species in which psilocin, psilocybin, peyote, mescaline dimethyltryptamine or ibogaine occurs naturally in any form.
In addition to this, the regulators would also be in charge of compiling research on the benefits and risks of psilocybin and reporting their findings on a public site.
In comparison, Connecticut’s bill is much more limited. Rep. Josh Elliot and four other lawmakers sponsored the Connecticut initiative, which would establish a task force to study psilocybin’s medicinal benefits.
Both of these initiatives follow a recent Senate bill introduced in the state of Hawaii that would set up a medical model for the legal therapeutic use of psilocybin. Over in New Jersey, lawmakers recently approved a measure that would decrease criminal penalties for psilocybin possession.
Aside from psychedelics, functional mushrooms are also poised to take the market by storm. Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) has positioned itself perfectly to be first in line to benefit from the projected $13.8 annual value of this market in Canada by 2024.
NOTE TO INVESTORS: The latest news and updates relating to Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) are available in the company’s newsroom at https://ibn.fm/PULL
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]
PsychedelicNewsWire is part of the InvestorBrandNetwork.
The post Connecticut, Florida Legislators File Psychedelic Mushroom Bills appeared first on PsychedelicNewsWire (PNW).
